Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Halozyme Therapeutics Inc. buy BiotechBee

Halozyme Therapeutics Inc.
Start price
€53.96
08.09.24 / 70%
Target price
€61.00
31.03.27
Performance (%)
-15.53%
End price
€45.58
14.12.24
Summary
This prediction ended on 14.12.24 with a price of €45.58. The prediction for Halozyme Therapeutics Inc. disappointed with a performance of -15.53%. BiotechBee has a follow-up prediction for Halozyme Therapeutics Inc. where he still thinks Halozyme Therapeutics Inc. is a Buy. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Halozyme Therapeutics Inc. -1.447% -1.447% 39.260%
iShares Core DAX® 3.258% 2.069% 10.102%
iShares Nasdaq 100 5.697% -0.604% 28.972%
iShares Nikkei 225® 7.770% -4.746% 52.094%
iShares S&P 500 2.795% 2.251% 23.747%

According to BiotechBee what are the pros and cons of Halozyme Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Halozyme Therapeu. diskutieren
Prediction Buy
Perf. (%) -15.53%
Target price 61.000
Change
Ends at 31.03.27

Buy mit Kursziel 61,0

BiotechBee 
0
Report Share
08.09.24
In the thread Trading Halozyme Therapeutics Inc.
Prediction Buy
Perf. (%) -15.53%
Target price 61.000
Change
Ends at 31.03.27

Buy beendet

BiotechBee 
0
Report Share
14.12.24

Current prediction by BiotechBee for Halozyme Therapeutics Inc.

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€71.72
03.08.26
€150.00
30.09.28
-0.59%
04.08.26

Could be very worthwhile Investment >20% year
BiotechBee 
03.08.26 80%